Immunology

Contributing journals to this collection:
JAMA & Archives Journals

Citations 161-170 of 1311 total displayed.

Past content

Observations
Continued Disease Activity in a Patient With Multiple Sclerosis After Allogeneic Hematopoietic Cell Transplantation

Jian-Qiang Lu; Jan Storek; Luanne Metz; V. Wee Yong; Anne M. Stevens; Richard A. Nash; Jeffrey T. Joseph
Arch Neurol 2009; 66: 116-120. [Abstract] [Full text] [PDF]  

The World in Medicine
Multiple Sclerosis Clue

Joan Stephenson
JAMA 2008; 300: 2717-b. [Extract] [Full text] [PDF]  

Lab Reports
Vitamin C and Chemotherapy

Carolyn J. Hildreth
JAMA 2008; 300: 2476-a. [Extract] [Full text] [PDF]  

Book and Media Reviews
Handbook of Human Immunology

Roshini S. Abraham; James T. Li
JAMA 2008; 300: 2553-2554. [Extract] [Full text] [PDF]  

Articles
Suitability of Forced Expiratory Volume in 1 Second/Forced Vital Capacity vs Percentage of Predicted Forced Expiratory Volume in 1 Second for the Classification of Asthma Severity in Adolescents

Christine van Dalen; Elizabeth Harding; Jill Parkin; Soo Cheng; Neil Pearce; Jeroen Douwes
Arch Pediatr Adolesc Med 2008; 162: 1169-1174. [Abstract] [Full text] [PDF]  

The Cutting Edge
Topical Sodium Thiosulfate Therapy for Leg Ulcers With Dystrophic Calcification

Elizabeth K. Wolf; Aimee C. Smidt; Anne E. Laumann
Arch Dermatol 2008; 144: 1560-1562. [Extract] [Full text] [PDF]  

Editorials
Central Nervous System Immune Surveillance: On Natalizumab, Dendritic Cells, and Dangerous Immune Privilege

Burkhard Becher
Arch Neurol 2008; 65: 1566-1567. [Extract] [Full text] [PDF]  

Original Contributions
Decrease in the Numbers of Dendritic Cells and CD4⁺ T Cells in Cerebral Perivascular Spaces Due to Natalizumab

Maria del Pilar Martin; Petra D. Cravens; Ryan Winger; Elliot M. Frohman; Michael K. Racke; Todd N. Eagar; Scott S. Zamvil; Martin S. Weber; Bernhard Hemmer; Nitin J. Karandikar; B. K. Kleinschmidt-DeMasters; Olaf Stüve
Arch Neurol 2008; 65: 1596-1603. [Abstract] [Full text] [PDF]  

Observations
Effect of Intravenous Immunoglobulin Therapy on Serum Levels of IgG1 and IgG4 Antidesmoglein 1 and Antidesmoglein 3 Antibodies in Pemphigus Vulgaris

Michelle G. Green; Jean-Claude Bystryn
Arch Dermatol 2008; 144: 1621-1624. [Abstract] [Full text] [PDF]  

Observations
Natalizumab Use in Pediatric Multiple Sclerosis

Peter Huppke; Wiebke Stark; Claudia Zürcher; Brenda Huppke; Wolfgang Brück; Jutta Gärtner
Arch Neurol 2008; 65: 1655-1658. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132